GC
Gratus Capital Portfolio holdings
AUM
$2.48B
This Quarter Return
+13.17%
1 Year Return
+32.66%
3 Year Return
+50.91%
5 Year Return
+137.89%
10 Year Return
–
AUM
$747M
AUM Growth
+$747M
(+17%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
5.42%
Top 10 Holdings %
Top 10 Hldgs %
25.46%
Holding
194
New
28
Increased
71
Reduced
60
Closed
12
Top Buys
| 1 |
LyondellBasell Industries
LYB
|
$10.5M |
| 2 |
iShares Core Dividend Growth ETF
DGRO
|
$7.95M |
| 3 |
Unity
U
|
$7.89M |
| 4 |
AT&T
T
|
$7.85M |
| 5 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
$7.38M |
Top Sells
| 1 |
iShares AAA-A Rated Corporate Bond ETF
QLTA
|
$8.94M |
| 2 |
Cisco
CSCO
|
$7.31M |
| 3 |
AstraZeneca
AZN
|
$6.84M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
$6.04M |
| 5 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$6.01M |
Sector Composition
| 1 | Technology | 16.75% |
| 2 | Healthcare | 11.37% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
SPDR S&P Dividend ETF
SDY
$20.6B
| $297K | 0.04% |
+2,803
| New | +$297K |
|
152
Deere & Co
DE
$129B
| $294K | 0.04% |
1,092
+4
| +0.4% | +$1.08K |
|
153
Peloton Interactive
PTON
$3.1B
| $288K | 0.04% |
+1,900
| New | +$288K |
|
154
Avnet
AVT
$4.55B
| $284K | 0.04% |
8,100
-700
| -8% | -$24.5K |
|
155
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| $284K | 0.04% |
2,010
-7
| -0.3% | -$989 |
|
156
FMC
FMC
$4.88B
| $276K | 0.04% |
2,400
| – | – |
|
157
J.M. Smucker
SJM
$11.8B
| $273K | 0.04% |
2,362
+245
| +12% | +$28.3K |
|
158
Unilever
UL
$155B
| $271K | 0.04% |
4,485
+1,226
| +38% | +$74.1K |
|
159
Biogen
BIIB
$19.4B
| $257K | 0.03% |
1,050
| – | – |
|
160
John Wiley & Sons Class A
WLY
$2.16B
| $256K | 0.03% |
+5,600
| New | +$256K |
|
161
GSK
GSK
$79.9B
| $255K | 0.03% |
6,917
+70
| +1% | +$2.58K |
|
162
Advance Auto Parts
AAP
$3.66B
| $238K | 0.03% |
1,509
| – | – |
|
163
Globe Life
GL
$11.3B
| $237K | 0.03% |
+2,492
| New | +$237K |
|
|
CMD
164
DELISTED
Cantel Medical Corporation
CMD
| $232K | 0.03% |
+2,940
| New | +$232K |
|
165
Norfolk Southern
NSC
$62.8B
| $230K | 0.03% |
+970
| New | +$230K |
|
166
Cardinal Health
CAH
$35.5B
| $229K | 0.03% |
4,271
-104
| -2% | -$5.58K |
|
167
Omnicell
OMCL
$1.5B
| $225K | 0.03% |
+1,875
| New | +$225K |
|
168
UGI
UGI
$7.44B
| $220K | 0.03% |
6,293
| – | – |
|
169
Manhattan Associates
MANH
$13B
| $217K | 0.03% |
+2,060
| New | +$217K |
|
170
Accenture
ACN
$162B
| $215K | 0.03% |
+825
| New | +$215K |
|
171
Elevance Health
ELV
$71.8B
| $214K | 0.03% |
+667
| New | +$214K |
|
172
Chegg
CHGG
$159M
| $206K | 0.03% |
+2,275
| New | +$206K |
|
173
Wells Fargo
WFC
$263B
| $206K | 0.03% |
+6,842
| New | +$206K |
|
174
ASGN Inc
ASGN
$2.38B
| $205K | 0.03% |
+2,450
| New | +$205K |
|
175
Entegris
ENTG
$12.7B
| $202K | 0.03% |
+2,100
| New | +$202K |
|